Overview
- Discusses new treatment approaches for COVID-19
- Describes the worldwide effort to develop effective vaccines
- Addresses a current global pandemic through positive and negative findings
- Describes effects of the virus in cases of co-morbidities
- Explores the mental health aspects and impact of the pandemic
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1327)
Part of the book sub series: Proteomics, Metabolomics, Interactomics and Systems Biology (PMISB)
Buy print copy
About this book
This new volume will increase readers’understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss new treatment approaches, vaccine development, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.
Similar content being viewed by others
Keywords
Table of contents (18 chapters)
-
Background
-
Risk Factors and Outcomes
-
Treatments and Vaccines
Editors and Affiliations
About the editor
Bibliographic Information
Book Title: Identification of Biomarkers, New Treatments, and Vaccines for COVID-19
Editors: Paul C. Guest
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-3-030-71697-4
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2021
Hardcover ISBN: 978-3-030-71696-7Published: 20 July 2021
eBook ISBN: 978-3-030-71697-4Published: 19 July 2021
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: IX, 234
Number of Illustrations: 4 b/w illustrations, 24 illustrations in colour
Topics: Virology, Biomedicine, general, Physiology